Therefore, HDGF is considered as an independent prognostic factor in patients with hepatocellular carcinoma [41], gastric cancer [19], pancreatic cancer [42], non–small-cell lung cancers [42], and gastrointestinal stromal tumors [43]. This evidence concerns the gene HDGF and gastrointestinal stromal tumor.